Navigation Links
NIH To Launch Two Major Gene and Disease Projects Soon

In order to better understand the role of genetic and environmental factors in the incidence of common diseases, the United States has planned to launch two major research studies// The National Institutes of Health (NIH) announced this recently.

The link between genes, environment and the disease would form the main focus of the study. One of the projects would revolve around the significance of genetic variation in increasing or decreasing susceptibility to diseases while the other would concentrate on parameters such as diet, pollution, behavior and type of work in the incidence of diseases.

Both the research project are hoped to identify innumerable number of genes that work together to increase or decrease risk of illness in a particular individual, according to Dr. Francis Collins, Director, National Human Genome Research Institute.

The project is estimated to run at a cost of approximately 60 million U.S. dollars that the NIH hopes to share with major pharmaceutical companies that express interest in a partnership. The NIH has volunteered to set apart a sum of 68 million dollars to support the project that would take nearly 3 years to complete.

Data from previous and ongoing studies would be used up for the project. Gene sequencing is yet another technique that would be taken up by the researchers, who would concentrate largely on the identification of single nucleotide polymorphism (SNPs) that are believed to confer enhanced or decreased disease susceptibility.

A lot of financial resources have been spent on the characterization of the genetic constitution of a number of individuals that will provide adequate data to study nearly 100 diseases. The list of diseases to be studied would be announced shortly by the NIH. In addition, scientists from all around the world are encouraged to participate in the research.

The development of sensors that can be worn by an individual to accurately pr edict blood and other biochemical changes following certain exposures is also under consideration by the NIH.


'"/>




Related medicine news :

1. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
2. Nutrient Profiling System Launched By Food Officials in UK
3. New Oat And Soy-Based Fat Replacer Launched
4. Launch Of India’s First Virology Course At Pun
5. Race Based Genome Project Launched By Mexico
6. Bird flu In Indonesia: Government To Launch ‘Village Preparedness’ Schee
7. Action Plan Against Drug Deaths Launched
8. New Fund Launched To Help HIV Positive Women
9. Use Of Viread Spreads As New Anti-AIDS Site Is Launched
10. Erectile Dysfunction Drug Viagra Launched In India By Pfizer
11. Serum Institute Launches New Tetanus-Diphtheria Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Catalent ... for drugs, biologics and consumer health products, today announced that Mr. Michael Merges, ... upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, on ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... the revolutionary Active Brake Technology (ABT), an innovative braking system that allows skaters ... Brake Technology addresses one of the biggest concerns of beginner and intermediate skaters ...
(Date:1/17/2017)... Michigan (PRWEB) , ... January 17, 2017 , ... January is National Stalking Awareness ... who choose to lurk in the corners and commit the crime of stalking, a very ... use and addiction, an often overlooked factor in stalking and other crimes. , “Stalking: know ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... point of difference. Eden Activewear is a stand-out company for several differences from ... online and only manufacture on demand, this is called 'Agile' manufacturing - ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
(Date:1/18/2017)... Safe Rx LLC and Good Day Pharmacy, ... Loveland, Colorado , today announced the availability ... Day locations.     "Patients with prescriptions prone ... storage," said Milton Cohen , President & CEO ... a cup of coffee, you can protect your children ...
(Date:1/18/2017)... In China , we say Health is ... China,s Healthy Strategy originates. 2016 is ... and Social Development of the People,s Republic of ... council of the People,s Republic of China ... plan, identifying medical devices as one of the main breakthrough ...
Breaking Medicine Technology: